Covered Pennsylvania health insurers would cover vaginal estrogen for menopause symptoms and urinary tract infection prevention, while patients could still owe part of the cost.
Covered Pennsylvania health insurers would cover vaginal estrogen to treat menopause symptoms and prevent urinary tract infections. Patients could still owe deductibles or copayments, and insurers could review whether treatment is needed.
Insurers would cover all FDA-approved drugs, devices, and combination products used to provide or administer vaginal estrogen. The requirement covers medical insurance policies. It excludes Medicare supplements, TRICARE, and the listed policies that provide limited benefits or cover other kinds of risks. Coverage would follow the policy's rules about whether treatment is medically needed, patient payments, and insurer reviews of care. The requirement covers policies offered, issued, or renewed in Pennsylvania after the act's effective date. The act would take effect 90 days after enactment. For policies requiring state filings, it would apply when a rate or form is first filed on or after that date. Other policies would be covered when issued or renewed on or after 180 days from that date.
No hearings or votes scheduled.